Clincosm LogoSign in Get a demo

Lymphoma, Non-Hodgkin

Showing NaN - NaN of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin Trial in Worldwide (Copanlisib (BAY80-6946), Placebo, Rituximab)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Copanlisib (BAY80-6946)
  • +7 more
  • Chandler, Arizona
  • +199 more
Jan 31, 2023

Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory Trial in United States

Completed
Has Results
  • Non-Hodgkin's Lymphoma, Relapsed
  • +8 more
  • PBCAR20A
  • +2 more
  • Duarte, California
  • +4 more
Jan 4, 2023

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-64264681)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • New York, New York
  • +15 more
Jan 27, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (Fludarabine, Cyclophosphamide, JCAR017)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Santa Monica, California
  • +36 more
Jan 25, 2023

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in New York (Venetoclax, Tazemetostat)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • New York, New York
    Weill Cornell Medicine/NewYork-Presberteryian Hospital
Jan 18, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (Standard of Care, JCAR017)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Standard of Care
  • JCAR017
  • Phoenix, Arizona
  • +78 more
Jan 13, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (RO7443904, Glofitamab, Obinutuzumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • New York, New York
  • +7 more
Jan 11, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,

Active, not recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +6 more
  • Duarte, California
  • +8 more
Jan 11, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (Ibrutinib, Rituximab, Ifosfamide)

Terminated
Has Results
  • Lymphoma, Non-Hodgkin
  • Los Angeles, California
  • +76 more
Nov 7, 2022

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +125 more
Nov 21, 2022

Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)

Recruiting
  • Lymphoma
  • +4 more
  • Pharmacokinetics
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 12, 2022

Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Worldwide (Relatlimab, Nivolumab)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • Hodgkin Disease
  • Phoenix, Arizona
  • +53 more
Aug 17, 2022

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-80948543)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Duarte, California
  • +18 more
Aug 11, 2022

Advanced Solid Tumor, NSCLC, Melanoma Trial in United States (AB308, Zimberelimab)

Recruiting
  • Advanced Solid Tumor
  • +9 more
  • Phoenix, Arizona
  • +20 more
May 2, 2022

Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Lymphoma, B-Cell
  • +4 more
  • Burbank, California
  • +90 more
Mar 31, 2022

Lymphoma, Non-Hodgkin Trial in Canada, United States (TAK-659, Bendamustine, Rituximab)

Terminated
Has Results
  • Lymphoma, Non-Hodgkin
  • Tucson, Arizona
  • +12 more
Dec 7, 2021

Lymphoma, Non-Hodgkin, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)

Completed
  • Lymphoma, Non-Hodgkin
  • HIV Infections
  • Bleomycin sulfate
  • +9 more
  • Los Angeles, California
  • +21 more
Oct 26, 2021

Lymphoma, Non-Hodgkin, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)

Completed
  • Lymphoma, Non-Hodgkin
  • HIV Infections
  • Bleomycin sulfate
  • +9 more
  • Los Angeles, California
  • +13 more
Oct 27, 2021

Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Non-Hodgkin Trial in United States (Autologous transplantation

Completed
Has Results
  • Lymphoma, B-Cell
  • +2 more
  • Autologous transplantation using rituxan/BEAM
  • Autologous transplantation using Bexxar/BEAM
  • New Haven, Connecticut
  • +35 more
Oct 21, 2021

Lymphoma Epidemiology of Outcomes Cohort Years 6-10

Enrolling by invitation
  • Lymphoma, Non-Hodgkin
    • Miami, Florida
    • +7 more
    Aug 20, 2021

    Lymphoma, Non-Hodgkin, Lymphoma, Large B-cell, Diffuse, Lymphoma, Follicular Trial in Canada, Germany, United States (TAK-659,

    Completed
    • Lymphoma, Non-Hodgkin
    • +2 more
    • Birmingham, Alabama
    • +14 more
    Aug 23, 2021

    NHL, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (veltuzumab)

    Completed
    • NHL
    • +17 more
    • veltuzumab
    • Savannah, Georgia
    • +4 more
    Aug 12, 2021

    Hodgkin Disease, Lymphoma, Non-hodgkin Trial in New York (Carfilzomib, TGR-1202)

    Terminated
    Has Results
    • Hodgkin Disease
    • Lymphoma, Non-hodgkin
    • New York, New York
      Columbia University Irving Medical Center - Center for Lymphoid
    Jun 28, 2021

    Ascertainment of Peripheral Blood or Saliva Samples for Genetic

    Active, not recruiting
    • Breast Neoplasms
    • +6 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jun 14, 2021

      Lymphoma, Non-Hodgkin Trial in Worldwide (Venetoclax, Cyclophosphamide, Obinutuzumab)

      Completed
      Has Results
      • Lymphoma, Non-Hodgkin
      • Fullerton, California
      • +51 more
      May 26, 2020